Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Temozolomide

85622-93-1C6H6N6O2194.154 g/mol

An imidazotetrazine that is 3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine which is substituted at positions 3, 4, and 8 by methyl, oxo, and carboxamide groups, respectively. A prodrug for MTIC (5-(3-methyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide, formed by spontaneous hydrolysis of temozolomide in the body), it is used as an oral alkylating agent for the treatment of newly diagnosed malignant glioblastoma multiforme (concomitantly with radiotherapy) and malignant melanoma. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number85622-93-1ChEBI ↗
Molecular formulaC6H6N6O2ChEBI ↗
Molar mass194.154 g/molChEBI ↗
Monoisotopic mass194.05522 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:72564ChEBI ↗

Cross-source molecular data

PubChem
Molar mass194.15 g/molPubChem ↗
Exact mass194.05522346 DaPubChem ↗
Computed XLogP-1.1PubChem ↗
Topological polar surface area (Ų)106PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors5PubChem ↗
Rotatable bonds1PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
temozolomide
3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
BPEGJWRSRHCHSN-UHFFFAOYSA-N
Cn1nnc2c(C(N)=O)ncn2c1=O
InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)

Names & synonyms

3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamideTemodalTemodartemozolomidatemozolomidum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

alkylating agentantiviral agentantineoplastic agentprodrug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00515055 mol

Uses 194.154 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
N
Nitrogen · 6 atoms
43.29%
C
Carbon · 6 atoms
37.12%
O
Oxygen · 2 atoms
16.48%
H
Hydrogen · 6 atoms
3.12%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
The efficacy of temozolomide for recurrent glioblastoma multiforme. ↗European journal of neurology · 2013 Feb · PMID 22680781
Temozolomide and unusual indications: review of literature. ↗Cancer treatment reviews · 2013 Apr · PMID 22818211
DE3231255 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:72564

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 5394 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.